Articles By Rob Wright, Chief Editor 2011-2021

Are You A Winner Or A Whiner?
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Friday, January 21, 2011
Occasionally I get a business book sent to me that I feel has some "golden  nuggets" I feel compelled to share with the Life Science Leader audience. By Rob Wright  Continue Reading..
  • The Wisdom Of Knowledge Transfer
    1/19/2011

    The baby boomers are hitting 65 this year. So, why is that important to pharma and bio companies? Think about it. For most traditional pharmaceutical companies, senior leadership is made up of baby boomers. By Rob Wright

  • VAWD: Impossible For Virtual Manufacturers In Maryland?
    1/12/2011

    Out-of-state virtual manufacturers (virtuals) wishing to continue to do business in Maryland must be scratching their heads. Here’s why. Maryland is now a Verified Accredited Wholesale Distributor (VAWD) state.

  • What's With The New Guy?
    1/7/2011

    The start of the new year often brings change. Here at Life Science Leader magazine, one of our biggest changes is that I have now assumed the role of chief editor. Perhaps you are asking yourself, what happened to Dan Schell? For the past 24 issues, Dan has been doing yeoman’s work.

  • Leadership As A Practice Is Broken, But Social Media Can Fix That
    1/4/2011

    I recently had a conversation with Mike Myatt, author of Leadership Matters...The CEO Survival Manual. From his perspective, leadership has become accountable to far too many of the wrong masters. By Rob Wright

  • National Mentoring Month
    1/3/2011

    I recently purchased a birthday card for my wife and realized that I spent more on this piece of paper than the cost of a gallon of gas. I have always been somewhat skeptical of purchasing cards for certain days of recognition and holidays for which I am unfamiliar or more likely, I perceive as marketing gimmicks. By Rob Wright

  • 10_0614_Feature_Pfizer_pic
    Lessons Learned Help Pfizer Accelerate Biotherapeutic Development

    Six of the seven blockbuster biotherapeutics belonging to Big Pharma have roots to small biotechs (see Table 1). So too does Tim Charlebois, Ph.D., VP of technology and innovation strategy within Pfizer’s biotherapeutics pharmaceutical sciences (BTx Pharm Sci).

Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL